Publications (130) Rocio Gonzalez-Conejero Hilla publications View referenced research data.

filter_list

2024

  1. Pacritinib prevents inflammation-driven myelofibrosis-like phenotype in a miR-146a-/- murine model

    Biomedicine and Pharmacotherapy, Vol. 181

  2. miR-146a−/− mice model reveals that NF-κB inhibition reverts inflammation-driven myelofibrosis-like phenotype

    American Journal of Hematology, Vol. 99, Núm. 7, pp. 1326-1337

  3. microRNAs and thrombo-inflammation: relationship in sight

    Current Opinion in Hematology, Vol. 31, Núm. 3, pp. 140-147

2023

  1. Inflammatory microRNAs in cardiovascular pathology: another brick in the wall

    Frontiers in Immunology, Vol. 14

  2. microRNAs as biomarkers of risk of major adverse cardiovascular events in atrial fibrillation

    Frontiers in Cardiovascular Medicine

2022

  1. MiR-146a Contributes to Thromboinflammation and Recurrence in Young Patients with Acute Myocardial Infarction

    Journal of Personalized Medicine, Vol. 12, Núm. 7

  2. Prognostic and Predictive Effects of Tumor and Plasma miR-200c-3p in Locally Advanced and Metastatic Breast Cancer

    Cancers, Vol. 14, Núm. 10

2021

  1. MiR-146a in cardiovascular diseases and sepsis: An additional burden in the inflammatory balance?

    Thrombosis and Haemostasis, Vol. 121, Núm. 9, pp. 1138-1150

  2. Micrornas as new regulators of neutrophil extracellular trap formation

    International Journal of Molecular Sciences, Vol. 22, Núm. 4, pp. 1-15

  3. Neutrophil extracellular traps and von Willebrand factor are allies that negatively influence COVID‐19 outcomes

    Clinical and Translational Medicine

  4. The pi3kδ inhibitor idelalisib diminishes platelet function and shows antithrombotic potential

    International Journal of Molecular Sciences, Vol. 22, Núm. 7

  5. miR-146a is a pivotal regulator of neutrophil extracellular trap formation promoting thrombosis

    Haematologica, Vol. 106, Núm. 6, pp. 1636-1646

2020

  1. Markers of endothelial cell activation and neutrophil extracellular traps are elevated in immune thrombocytopenia but are not enhanced by thrombopoietin receptor agonists

    Thrombosis Research, Vol. 185, pp. 119-124

  2. Pilot study on the role of circulating mirnas for the improvement of the predictive ability of the 2mace score in patients with atrial fibrillation

    Journal of Clinical Medicine, Vol. 9, Núm. 11, pp. 1-11

  3. Platelet activation and neutrophil extracellular trap (NET) formation in immune thrombocytopenia: is there an association?

    Platelets, Vol. 31, Núm. 7, pp. 906-912

  4. miR-146a rs2431697 identifies myeloproliferative neoplasm patients with higher secondary myelofibrosis progression risk

    Leukemia, Vol. 34, Núm. 10, pp. 2648-2659

2019

  1. Effect of CYP4F2, VKORC1, and CYP2C9 in Influencing Coumarin Dose: A Single-Patient Data Meta-Analysis in More Than 15,000 Individuals

    Clinical Pharmacology and Therapeutics, Vol. 105, Núm. 6, pp. 1477-1491

  2. MicroRNAs as potential regulators of platelet function and bleeding diatheses

    Platelets, Vol. 30, Núm. 7, pp. 803-808

  3. Neutrophil extracellular trap components increase the expression of coagulation factors

    Biomedical Reports, Vol. 10, Núm. 3, pp. 195-201

2018

  1. Circulating microRNAs as biomarkers of disease and typification of the atherothrombotic status in antiphospholipid syndrome

    Haematologica, Vol. 103, Núm. 5, pp. 908-918